Liposomal Bupivacaine vs Ropivacaine for TAPBs

PHASE3RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

May 20, 2024

Study Completion Date

June 30, 2024

Conditions
Abdominal TumorPostoperative AnalgesiaLiposomal BupivacaineRopivacaine
Interventions
DRUG

Liposomal Bupivacaine

After induction of anesthesia, bilateral TAPB was performed under ultrasound guidance. The patients in the bupivacaine liposome group were injected with bupivacaine liposome 133mg(10ml+ 10ml 0.9% normal saline mixed into 20ml)/ point (two points in total).

DRUG

Ropivacaine

Patients in ropivacaine group were given 0.25% ropivacaine 20ml/ point (two points in total).

Trial Locations (1)

510060

RECRUITING

Jingdun Xie, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER